Skip to main content
Premium Trial:

Request an Annual Quote

Alliances Pay Off as Millennium s Q3 Loss Narrows

NEW YORK, Oct. 16 - Millennium Pharmaceuticals on Tuesday reported narrowed third-quarter losses as revenue from strategic alliances nearly doubled. 

The Cambridge, Mass.-based company said its loss from operations narrowed to $9.5 million, or 4 cents a share, from a loss of $31.9 million, or 16 cents, year over year. 

Revenues from alliances grew to $82 million over the current quarter from $44 million over the same period last year.

Results from both periods exclude acquisition-related charges. 

Including one-time items, the net loss in the quarter ended Sept. 30 was 11 cents a share compared with a loss of 49 cents for the same period one year ago. 

Analysts polled by Thomson Financial/First Call predicted a loss of 15 cents for the quarter.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.